SCHEMBL296131

SCHEMBL296131

[CH2]c1nc2ccccc2cc1-c1ccc2ccccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.46
RAB9A P51151 9/20 0.46
AR P10275 9/20 0.46
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 7/20 0.45
HPGD P15428 4/20 0.45
MAPT P10636 3/20 0.45
GLA P06280 1/20 0.45
ACHE P22303 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
KDM4E B2RXH2 5/20 0.43
HSD17B10 Q99714 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11614311 0.78 AR (0.49) NPC1RAB9AARCYP3A4CYP1A2
SCHEMBL7369914 0.77 ALDH1A1 (0.51) NPC1RAB9AALDH1A1HPGDMAPT
SCHEMBL12853993 0.76 PTGS2 (0.57) NPC1RAB9AARCYP3A4CYP1A2
SCHEMBL21037673 0.76 AR (0.50) NPC1RAB9AARCYP3A4CYP1A2
SCHEMBL31038123 0.76 AR (0.55) NPC1RAB9AARCYP3A4CYP1A2
SCHEMBL21215650 0.76 ALDH1A1 (0.52) NPC1RAB9AARCYP3A4CYP1A2
SCHEMBL29374931 0.75 RAB9A (0.64) NPC1RAB9AARCYP3A4CYP1A2
SCHEMBL170196 0.75 RAB9A (0.64) NPC1RAB9AARCYP3A4CYP1A2
SCHEMBL13408682 0.74 AR (0.49) NPC1RAB9AARCYP3A4CYP1A2
Bromide SCHEMBL20502170 0.74 PTGS2 (0.56) NPC1RAB9AARCYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948627-B1 NOVEL DUAL PEPTIDASE INHIBITORS AS PRODRUGS FOR THE THERAPY OF INFLAMMATORY AND OTHER DISORDERS IMTM GMBH (DE) 2012-03-14 EP disclosed
EP-2178527-A1 METHOD FOR ACTIVATING REGULATORY T-CELLS IMTM GmbH (DE) 2010-04-28 EP disclosed
WO-2009024348-A1 METHOD FOR ACTIVATING REGULATORY T-CELLS IMTM GMBH (DE) 2009-02-26 WO disclosed